Guide

Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs): Is Machine Translation a Viable Option?

As technology continues to advance and the need to expedite drug development increases, the applications of Machine Translation (MT) and Artificial Intelligence (AI) in the translation process should be further explored. The capabilities of iterative learning and feedback can serve as a tool for translation, but the limitations should be considered. This poster will compare human translation (HT) and machine translation (MT) in the back translation step for Clinical Outcome Assessments (COAs) as well as supporting study materials.